Rang	Name	Position
1	Dr. Douglas G. Cole M.D.	Founder & Independent Chairman of the Board
2	Mr. Adrian H. B. Gottschalk	President, CEO & Director
3	Dr. Steven F. Bellon Ph.D.	Chief Scientific Officer
4	Dr. Alfonso Quintas Cardama M.D.	Chief Medical Officer
5	Dr. Gerald R. Crabtree M.d.	Founder & Member of Scientific Advisory Board
6	Mr. Ryan D. Maynard	Chief Financial Officer
7	Ms. Karin Hellsvik	Chief of Staff to the CEO, VP, Head of Corporate Affairs, Investor Relations & Operations
8	Mr. Michael J. LaCascia J.D.	Chief Legal Officer
9	Mr. Saurabh Sewak Ph.D.	Vice President of Corporate Development
10	Mr. Carlos Costa	Chief People Officer

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Flagship Ventures Management, Inc.	21,34%	25,60 Mio. USD
2	Bvf Inc	9,84%	11,80 Mio. USD
3	FMR Inc	9,61%	11,53 Mio. USD
4	Deerfield Management Co	7,40%	8,88 Mio. USD
5	BlackRock Inc	4,42%	5,31 Mio. USD
6	Euclidean Capital LLC	2,65%	3,18 Mio. USD
7	Vanguard Capital Management, LLC	2,52%	3,02 Mio. USD
8	Geode Capital Management, LLC	1,53%	1,84 Mio. USD
9	Siren, L.L.C.	1,21%	1,46 Mio. USD
10	State Street Corp	1,17%	1,41 Mio. USD
11	Ameriprise Financial Inc	0,76%	0,91 Mio. USD
12	Renaissance Technologies Corp	0,64%	0,76 Mio. USD
13	Candriam Luxembourg S.C.A.	0,53%	0,63 Mio. USD
14	Northern Trust Corp	0,52%	0,63 Mio. USD
15	Jacobs Levy Equity Management, Inc.	0,51%	0,62 Mio. USD
16	Vanguard Portfolio Management, LLC	0,51%	0,62 Mio. USD
17	Birchview Capital, LP	0,47%	0,57 Mio. USD
18	Vanguard Fiduciary Trust Co	0,45%	0,53 Mio. USD
19	Qube Research & Technologies	0,34%	0,41 Mio. USD
20	Woodline Partners LP	0,34%	0,41 Mio. USD